| Basics |
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.
|
| IPO Date: |
June 23, 2000 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$508.76M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.13 | 3.54%
|
| Avg Daily Range (30 D): |
$0.05 | 3.45%
|
| Avg Daily Range (90 D): |
$0.05 | 3.65%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.36M |
| Avg Daily Volume (30 D): |
1.81M |
| Avg Daily Volume (90 D): |
2.15M |
| Trade Size |
| Avg Trade Size (Sh.): |
266 |
| Avg Trade Size (Sh.) (30 D): |
359 |
| Avg Trade Size (Sh.) (90 D): |
441 |
| Institutional Trades |
| Total Inst.Trades: |
1,001 |
| Avg Inst. Trade: |
$1.49M |
| Avg Inst. Trade (30 D): |
$1.01M |
| Avg Inst. Trade (90 D): |
$.83M |
| Avg Inst. Trade Volume: |
.2M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.29M |
| Avg Closing Trade (30 D): |
$1.01M |
| Avg Closing Trade (90 D): |
$.83M |
| Avg Closing Volume: |
195.48K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.19
|
$-.04
|
$.01
|
|
Diluted EPS
|
$-.19
|
$-.04
|
$.01
|
|
Revenue
|
$ 70.86M
|
$ 14.18M
|
$ 28.87M
|
|
Gross Profit
|
$ 70.44M
|
$ 14.17M
|
$ 28.83M
|
|
Net Income / Loss
|
$ -68.58M
|
$ -12.77M
|
$ 3.25M
|
|
Operating Income / Loss
|
$ -66.87M
|
$ -12.19M
|
$ 3.74M
|
|
Cost of Revenue
|
$ .42M
|
$ .01M
|
$ .03M
|
|
Net Cash Flow
|
$ 44.11M
|
$ 28.29M
|
$ -12.52M
|
|
PE Ratio
|
|
|
|
|
|
|
